Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Obes (Lond) ; 45(8): 1656-1667, 2021 08.
Article in English | MEDLINE | ID: mdl-33947969

ABSTRACT

BACKGROUND/OBJECTIVES: Adipose tissue macrophages (ATMs) exist in either the M1 or M2 form. The anti-inflammatory M2 ATMs accumulate in lean individuals, whereas the pro-inflammatory M1 ATMs accumulate in obese individuals. Bee venom phospholipase A2 (bvPLA2), a major component in honeybee (Apis mellifera) venom, exerts potent anti-inflammatory effects via interactions with regulatory T cells (Treg) and macrophages. This study investigated the effects of bvPLA2 on a high-fat diet (HFD)-induced obesity in mice. SUBJECTS/METHODS: For in vivo experiments, male C57BL/6, CD206-deficient, and Treg-depleted mice models were fed either a normal diet 41.86 kJ (ND, 10 kcal% fat) or high-fat diet 251.16 kJ (HFD, 60 kcal% fat). Each group was i.p. injected with PBS or bvPLA2 (0.5 mg/kg) every 3 days for 11 weeks. Body weight and food intake were measured weekly. Histological changes in the white adipose tissue (WAT), liver, and kidney as well as the immune phenotypes of the WAT were examined. Immune cells, cytokines, and lipid profiles were also evaluated. The direct effects of bvPLA2 on 3T3-L1 pre-adipocytes and bone marrow-derived macrophages were measured in vitro. RESULTS: bvPLA2 markedly decreased bodyweight in HFD-fed mice. bvPLA2 treatment also decreased lipid accumulation in the liver and reduced kidney inflammation in the mice. It was confirmed that bvPLA2 exerted immunomodulatory effects through the CD206 receptor. In addition, bvPLA2 decreased M1 ATM and alleviated the M1/M2 imbalance in vivo. However, bvPLA2 did not directly inhibit adipogenesis in the 3T3-L1 adipose cells in vitro. CONCLUSIONS: bvPLA2 is a potential therapeutic strategy for the management of obesity by regulating adipose tissue macrophage homeostasis.


Subject(s)
Adipose Tissue/cytology , Bee Venoms , Macrophages/drug effects , Obesity/metabolism , Phospholipases A2 , 3T3-L1 Cells , Adipose Tissue, White/drug effects , Animals , Bee Venoms/enzymology , Bee Venoms/pharmacology , Diet, High-Fat/adverse effects , Male , Mice , Mice, Inbred C57BL , Phospholipases A2/metabolism , Phospholipases A2/pharmacology
2.
J Biophotonics ; 5(10): 777-84, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22415866

ABSTRACT

The viscoelastic properties of synovial fluid (SF) are critical to its functions of lubrication and shock-absorption of joints in human body; a change in the viscoelastic properties, even of only a few percents, is often concomitant with arthritis. In this work, the elastic modulus G '(f) and the viscous modulus G ''(f) of SF from patients suffering from three kinds of joint diseases, namely, osteoarthritis (OA), rheumatoid arthritis (RA), and gouty arthritis (GA), were determined as a function of frequency "f " (in the low frequency range from f ∼ 0.1 to 10 Hz) by Diffusing Wave Spectroscopy (DWS) and correlated with the white blood cell (WBC) count. A strong correlation was observed, showing a higher WBC count corresponding to lower elastic and viscous moduli, G ' and G ''; further details depend on inflammatory vs. non-inflammatory, and on the severity of inflammation. Different types of arthritis lead to different degrees of decreasing viscoelasticity. Identical measurements were carried out with a commercial visco-supplementation (or artificial SF) to serve as reference. In general, the reduction in both G ' and G '' was most severe in the case of GA and least severe in the case of OA. Besides, in all cases, the reduction in G ' was more prominent than the reduction in G '', indicating that in general, the deterioration in the elasticity of SF by inflammation is more severe than that in the viscosity. This simple method for quantitative physical characterization of synovial fluid may serve as a useful complementary metric to the conventional biochemical analysis in clinical diagnosis of arthritis.


Subject(s)
Arthritis/metabolism , Rheology/methods , Spectrum Analysis/methods , Synovial Fluid/metabolism , Arthritis/pathology , Arthritis/physiopathology , Elastic Modulus , Humans , Leukocyte Count , Movement , Stress, Physiological , Viscosity
3.
Pharmacology ; 67(4): 202-10, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12595751

ABSTRACT

The pharmacological effects of BDPBI (7-bromo-1,4-dihydro-2-phenyl-4,4-bis(4-pyridinylmethyl)2H-isoquinolin-3-one dihydrochloride) were tested on isolated endothelium-containing or denuded aorta of the guinea pig. BDPBI with the formula C(27)H(24)BrCl(2)N(3)O was synthesized starting with 3-isochromanone. In the endothelium-containing preparations of the aortic rings, phenylephrine (PHE; 10 micromol/l) elicited contracture and acetylcholine (ACh; 10 micromol/l) or BDPBI (0.01-10 micromol/l) elicited relaxation effects on the PHE-precontracted preparations. The BDPBI-elicited effect on the PHE-precontracted aortic rings was not altered in the presence of adrenergic blockers (propranolol or yohimbine; 1 micromol/l) or pretreated preparations with aspirin, indomethacin (10 micromol/l) or L-NAME (1 mmol/l). However, the relaxation effects of BDPBI were blocked if the preparations were pretreated with diphenhydramine (10 micromol/l) or chloropheniramine maleate (10 micromol/l). In contrast to lower concentrations of atropine (1 micromol/l), higher concentrations of atropine (30 micromol/l) did block the effects of BDPBI on the PHE-precontracted aortic rings. HTMT dimaleate (0.01-10 micromol/l), a histamine H(1) receptor agonist, also elicited relaxation effects on the PHE-precontracted preparation, and the effects were blocked if the preparations were pretreated with diphenhydramine or chloropheniramine maleate. On isolated denuded aorta of the guinea pig, BDPBI did not elicit relaxation effects on the PHE-precontracted aortic rings. These results demonstrated that the vasorelaxation effect of BDPBI on PHE-precontracted aortic rings is partly dependent on the activation of a histaminergic receptor from the vascular endothelium. We suggested that BDPBI would be an effective vasorelaxant for cardiovascular systems.


Subject(s)
Aorta, Thoracic/drug effects , Isoquinolines/pharmacology , Pyridines/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Acetylcholine/pharmacology , Adrenergic Antagonists/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aorta, Thoracic/physiology , Aspirin/pharmacology , Atropine/pharmacology , Chlorpheniramine/pharmacology , Cimetidine/pharmacology , Diphenhydramine/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/physiology , Guinea Pigs , Histamine H1 Antagonists/pharmacology , Histamine H2 Antagonists/pharmacology , In Vitro Techniques , Indomethacin/pharmacology , Isoquinolines/chemistry , Magnetic Resonance Spectroscopy , Male , Muscarinic Antagonists/pharmacology , Phenylephrine/pharmacology , Propranolol/pharmacology , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/chemistry , Yohimbine/pharmacology
4.
Bioorg Med Chem ; 10(10): 3267-76, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12150872

ABSTRACT

Based on the most stable conformation of ZD6169, a series of N-arylated derivatives of oxazolidindione (2), morpholin-3-one (3-5), piperidin-2-one (6), and pyrrolidin-2-one (7-13) was synthesized and evaluated for potassium channel opening activity. In the in-vitro assays, N-(4-benzoylphenyl)-piperidin-2-on (6) and N-(4-benzoylphenyl)-3,3-dimethyl-pyrrolidin-2-one (9) demonstrated potent and selective relaxant activity at the bladder detrusor muscle [IC50, bladder)=7.4 and 6.7 microM, respectively; IC50 ratio (portal vein/bladder)=41 and 51, respectively].


Subject(s)
Ion Channel Gating/drug effects , Morpholines/pharmacology , Potassium Channels/drug effects , Pyrrolidinones/pharmacology , Amides/chemistry , Animals , Benzophenones/chemistry , Male , Morpholines/chemical synthesis , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Portal Vein , Potassium Channels/agonists , Pyrrolidinones/chemical synthesis , Rats , Rats, Wistar , Structure-Activity Relationship , Urinary Bladder , Urinary Incontinence/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...